News

ADVANCE Blueprint submitted to IMI

02/10/2018

The WP7 deliverable D7.7 Blueprint of a framework to rapidly provide scientific evidence on post-marketing vaccination benefits and risks for informed decisions has been submitted to IMI. Click here to read more.